Literature DB >> 19467320

Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains.

Daniela M Ferreira1, Adriana T Moreno, Aurora M Cianciarullo, Paulo L Ho, Maria Leonor S Oliveira, Eliane N Miyaji.   

Abstract

The differences between the immune response elicited during a self-limiting and a life-threatening lung infection with Streptococcus pneumoniae was analyzed in a mouse model of intranasal challenge using two different pneumococcal strains. M10, a serotype 11A strain, induced an early response within the first 12h after the challenge, which was characterized by the early local secretion of TNF-alpha and IL-6, followed by a sharp and rapid neutrophil influx. Bacterial loads in the lungs already started to fall at 12h after the challenge and no pneumococci could be recovered after 36h, at the time point when the animals started to show improvement in disease symptoms. ATCC6303, a serotype 3 strain, on the other hand, showed only a late increase in local TNF-alpha and IL-6 levels, when bacterial growth already seems to be out of control. Although cell influx was also observed, neutrophil rise was not as marked as with M10 (type 11A). Pneumococcal loads increased constantly and bacteria started to be recovered from the blood at 30h after the challenge. After this time point, animals showed worsening of symptoms and became lethargic. The resolution of the acute infection could be thus correlated with the early induction of proinflammatory cytokines, which could be due to the presence of a thinner polysaccharide capsule in M10 (type 11A), rendering bacterial components capable of activating the innate immune response more accessible.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19467320     DOI: 10.1016/j.micpath.2009.05.005

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  11 in total

1.  Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.

Authors:  Yushi Yao; Rocky Lai; Sam Afkhami; Siamak Haddadi; Anna Zganiacz; Fatemeh Vahedi; Ali A Ashkar; Charu Kaushic; Mangalakumari Jeyanathan; Zhou Xing
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

2.  The innate immune response to Streptococcus pneumoniae in the lung depends on serotype and host response.

Authors:  Beza Seyoum; Masahide Yano; Liise-anne Pirofski
Journal:  Vaccine       Date:  2011-08-22       Impact factor: 3.641

3.  Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice.

Authors:  Fernanda A Lima; Daniela M Ferreira; Adriana T Moreno; Patrícia C D Ferreira; Giovana M P Palma; Jorge M C Ferreira; Isaias Raw; Eliane N Miyaji; Paulo L Ho; Maria Leonor S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2012-07-03

4.  Immunization with pneumococcal polysaccharide serotype 3 and lipopolysaccharide modulates lung and liver inflammation during a virulent Streptococcus pneumoniae infection in mice.

Authors:  Katherine H Restori; Mary J Kennett; A Catharine Ross
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

5.  Streptococcus pneumoniae-induced pneumonia and Citrobacter rodentium-induced gut infection differentially alter vitamin A concentrations in the lung and liver of mice.

Authors:  Katherine H Restori; Kaitlin L McDaniel; Amanda E Wray; Margherita T Cantorna; A Catharine Ross
Journal:  J Nutr       Date:  2014-01-15       Impact factor: 4.798

6.  Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.

Authors:  Maria Leonor S Oliveira; Eliane N Miyaji; Daniela M Ferreira; Adriana T Moreno; Patricia C D Ferreira; Fernanda A Lima; Fernanda L Santos; Maria Aparecida Sakauchi; Célia S Takata; Hisako G Higashi; Isaías Raw; Flavia S Kubrusly; Paulo L Ho
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

7.  L-plastin is essential for alveolar macrophage production and control of pulmonary pneumococcal infection.

Authors:  Lauren E Deady; Elizabeth M Todd; Chris G Davis; Julie Y Zhou; Nermina Topcagic; Brian T Edelson; Thomas W Ferkol; Megan A Cooper; Jared T Muenzer; Sharon Celeste Morley
Journal:  Infect Immun       Date:  2014-03-04       Impact factor: 3.441

8.  Adverse effects of wood smoke PM(2.5) exposure on macrophage functions.

Authors:  Christopher T Migliaccio; Emily Kobos; Quinton O King; Virginia Porter; Forrest Jessop; Tony Ward
Journal:  Inhal Toxicol       Date:  2013-02       Impact factor: 2.724

9.  Kinase activity profiling of pneumococcal pneumonia.

Authors:  Arie J Hoogendijk; Sander H Diks; Tom van der Poll; Maikel P Peppelenbosch; Catharina W Wieland
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

10.  Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage.

Authors:  Adam K A Wright; Daniela M Ferreira; Jenna F Gritzfeld; Angela D Wright; Kathryn Armitage; Kondwani C Jambo; Emily Bate; Sherouk El Batrawy; Andrea Collins; Stephen B Gordon
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.